The long-term goal of our research is to identify and develop novel and efficacious therapeutic regimens forthe treatment of human cancer, particularly head and neck cancer (HNC). The current application aimsspecifically at targeting death receptor-mediated apoptotic pathways for the treatment of HNC, particularlymetastatic HNC, through evaluating the potential of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) or perifosine and TRAIL in combination in the treatment of metastatic HNC. Our gene array andWestern blotting data indicate that highly metastatic HNC cell lines express increased levels of deathreceptor 5 (DR5), FADD, caspase-8 and caspase-9 and low levels of c-FLIP(L) although they exhibitundetectable levels of TRAIL and high levels of c-FLIP(S). Importantly these cell lines are highly sensitive toexogenous TRAIL treatment. Perifosine, the first oral alkylphospholipid with Akt-inhibitory activity in clinicaltrials, further upregulates the expression of DR5, reduces c-FLIP levels and very effectively inducesapoptosis in these metastatic HNC cell lines. Based on these findings, we hypothesize that highly metastaticHNC cells retain high potential to undergo DR5-mediated apoptosis, albeit with dysregulated apoptoticsignaling. Thus, agents including TRAIL and perifosine that activate the DR5-mediated apoptoticpathwaymay be effective in treatment of metastatic HNC. These hypotheses will be tested by accomplishing thefollowing specific aims: 1) Determine the mechanism(s) by which perifosine and TRAIL cooperatively induceapoptosis of metastatic HNC cells; 2) Determine the efficacy of TRAIL and its combination with perifosine inan in vivo model of HNC metastasis; and 3) Determine differential expression patterns of selected genes(e.g., TRAIL, DR5, c-FLIP, and caspase-8) primarily involved in the extrinsic apoptotic pathway betweenprimary and metastatic human HNC tissues, and evaluate their prognostic values. The accomplishmentofthese aims will allow us to assess the efficacy of TRAIL and its combination with perifosine in the treatmentof HNC, particularly metastatic HNC, in vitro and in vivo, reveal the underlying mechanisms of perifosine andTRAIL synergism, and demonstrate the role of dysregulation of the extrinsic apoptotic pathway in HNCmetastasis and its prognostic value. The results generated from this project can be directly translated toclinical practice for the better treatment of HNC patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA128613-01
Application #
7300625
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-08-23
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$331,014
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Gleber-Netto, Frederico O; Zhao, Mei; Trivedi, Sanchit et al. (2018) Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 124:84-94
Wang, Xu; Beitler, Jonathan J; Huang, Wen et al. (2018) Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin. Clin Cancer Res 24:858-869
Pai, Sara I; Jack Lee, J; Carey, Thomas E et al. (2018) HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers. Oral Oncol 77:92-97
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188
Pike, Robert; Lu, Guolan; Wang, Dongsheng et al. (2016) A Minimum Spanning Forest-Based Method for Noninvasive Cancer Detection With Hyperspectral Imaging. IEEE Trans Biomed Eng 63:653-63
Majumdar, Debatosh; Rahman, Mohammad Aminur; Chen, Zhuo Georgia et al. (2016) Anticancer activity of drug conjugates in head and neck cancer cells. Front Biosci (Elite Ed) 8:358-69
Oh, Y-T; Deng, J; Yue, P et al. (2016) Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing. Oncogene 35:459-67
Oh, You-Take; Yue, Ping; Wang, Dongsheng et al. (2015) Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling. Oncotarget 6:41324-38
Haque, Abedul; Rahman, Mohammad Aminur; Chen, Zhuo Georgia et al. (2015) Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2. Apoptosis 20:986-95
Amin, A R M Ruhul; Haque, Abedul; Rahman, Mohammad Aminur et al. (2015) Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways. PLoS One 10:e0124218

Showing the most recent 10 out of 136 publications